Koyfin Home > Directory > Health Care > Akcea Therapeutics Inc > Price / Earnings (ltm)

Akcea Therapeutics Inc Price / Earnings (ltm) Chart (AKCA)

Akcea Therapeutics Inc annual/quarterly Price / Earnings (ltm) from 2020 to 2020. The price-earnings ratio (P/E ratio) is the ratio for valuing a company that measures its current share price relative to its consensus EPS estimate of the next twelve months (NTM). The price-earnings ratio is also sometimes known as the price multiple or the earnings multiple.
  • Akcea Therapeutics Inc Price / Earnings (ltm) for the quarter ending May 05, 2020 was 57.94 a -2.96% decrease of -1.71 year over year
  • Akcea Therapeutics Inc Price / Earnings (ltm) for the last 12 months ending May 05, 2020 was 57.94 a -2.96% decrease of -1.71 year over year
  • Akcea Therapeutics Inc Annual Price / Earnings (ltm) for 2020 was 57.94 a 2.72% increase of 1.57 from 2019
  • Akcea Therapeutics Inc Annual Price / Earnings (ltm) for 2020 was 56.36 a 6.14% increase of 3.46 from 2019
  • Akcea Therapeutics Inc Annual Price / Earnings (ltm) for 2020 was 52.90 a -12.76% decrease of -6.75 from 2019
Other Valuation Metrics:
  • Akcea Therapeutics Inc Market Cap for the quarter ending March 03, 2018 was $1,709m
  • Akcea Therapeutics Inc Price / Book for the quarter ending March 03, 2018 was 9.49
  • Akcea Therapeutics Inc Enterprise Value for the quarter ending March 03, 2018 was $1,449m
View Chart On Koyfin

Quarterly AKCA Price / Earnings (ltm) Data

05/202057.94
05/202056.36
05/202052.90
04/202059.65
04/202062.41
04/202060.91
04/202062.76
04/202062.94
04/202062.41
04/202059.44

Annual AKCA Price / Earnings (ltm) Data

202057.94
202056.36
202052.90
202059.65
202062.41
202060.91
202062.76
202062.94
202062.41
202059.44